Lexington Biosciences Inc (LXGTF)
OTHER OTC:LXGTF
US Market
Holding LXGTF?
Track your performance easily

Lexington Biosciences (LXGTF) Financial Statements

8 Followers

Lexington Biosciences Financial Overview

Lexington Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Lexington Biosciences is scheduled to report earnings on November 29, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -65.60KC$ -42.11KC$ -45.00KC$ -36.63KC$ -40.82K
EBITDAC$ -65.60KC$ -42.11KC$ -45.00KC$ -36.63KC$ -40.82K
Net Income Common StockholdersC$ -65.60KC$ -42.11KC$ -45.00KC$ -36.63KC$ -40.82K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 0.00C$ 0.00C$ 0.00C$ 664.00C$ 664.00
Total Assets---C$ 664.00C$ 664.00
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ 0.00C$ 0.00C$ 0.00C$ -664.00C$ -664.00
Total LiabilitiesC$ 856.70KC$ 853.52KC$ 811.41KC$ 1.95MC$ 1.91M
Stockholders EquityC$ -919.12KC$ -853.52KC$ -811.41KC$ -1.95MC$ -1.91M
Cash Flow-
Free Cash Flow--C$ -664.00C$ 1.00KC$ -967.00
Operating Cash Flow--C$ -664.00C$ 1.00KC$ -967.00
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CAD

Lexington Biosciences Earnings and Revenue History

Lexington Biosciences Debt to Assets

Lexington Biosciences Cash Flow

Lexington Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis